Interventional Oncology Devices | Market Analysis | Asia Pacific | 2019
Despite pricing pressures and the release of mixed clinical data, the Asia Pacific interventional oncology device market will expand rapidly through 2027, driven by the continued growth of cancer incidence, improving access to treatment, and the entry of new foreign and domestic competitors.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in the Asia Pacific region across a 10-year period.
